Derma Sciences, Inc. Common Stock (DE)
DSCI
DSCI was delisted on the 23rd of February, 2017.
70 hedge funds and large institutions have $171M invested in Derma Sciences, Inc. Common Stock (DE) in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 13 reducing their positions, and 11 closing their positions.
138% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 73 → 70 (-3)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
32% less capital invested
Capital invested by funds: $251M → $171M (-$80.5M)
85% less call options, than puts
Call options by funds: $145K | Put options by funds: $957K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
+$1.92M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$927K |
| 3 |
CCM
Consonance Capital Management
New York
|
+$636K |
| 4 |
RAM
Roanoke Asset Management
Jersey City,
New Jersey
|
+$409K |
| 5 |
DM
Deerfield Management
New York
|
+$335K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$6.94M |
| 2 |
PA
Perceptive Advisors
New York
|
-$1.77M |
| 3 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$1.54M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$695K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$632K |
DSCI Hedge Fund Activity: Q3 2014 in Review
70 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q3 2014, worth a combined $171M — down 32% from $251M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of DSCI and 8 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 31 added.
The largest buyer was Senvest Management, adding an estimated $1.92M. The largest seller was Redmile Group, exiting entirely with an estimated $6.94M sold.
- 70 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q3 2014, down from 73 in Q2 2014.
- Funds reported $171M of Derma Sciences, Inc. Common Stock (DE) stock for Q3 2014, down 32% quarter-over-quarter.
- 8 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q3 2014 and 11 closed out, a net change of -3 holders.
- The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q3 2014 was Senvest Management, an estimated $1.92M added.
- The largest Derma Sciences, Inc. Common Stock (DE) seller in Q3 2014 was Redmile Group, an estimated $6.94M sold.
Based on aggregated 13F filings for Q3 2014.